Iranian Journal of Public Health 2018. 47(5):768-769.

Survival Rate in Thalassemia Major Patients: Difference between Date of Diagnosis and Date of Birth as an Index Date for Calculating Follow Up


No Abstract####


No keywords##

Full Text:



Sanlidag B, Cagin B, Ozenli O et al (2016). Prevalence of Thalassemia Trait & Iron Deficiency Anemia during Infancy in 2011-2013 in a Thalassemia Prevalent Region: North Cyprus. Iran J Public Health, 45(8):1038-43.

Sabbah HA, Hamadna A, Ghazaleh LA et al (2013). Diagnosis of new cases of β-thalassaemia major after prenatal testing: a cross-sectional survey. Lancet, 382(S4):4.

Hassanzadeh J, Mirahmadizadeh A, Karimi M, Rezaeian S (2017). Delay in Diagnosis of Hemoglobulinopathies (Thalassemia, Sickle Cell Anemia): A Need for Management of Thalassemia Programs. Iran J Pediatr, 27(2):e6740.

Wu HP, Lin CL, Chang YC et al (2017). Survival and complication rates in patients with thalassemia major in Taiwan. Pediatr Blood Cancer, 64(1):135-8.

Autier P (2016). Age at cancer diagnosis and interpretation of survival statistics. Lancet Oncol, 17(7):847-8.

Ozturk C, Fleer J, Hoekstra HJ, Hoekstra-Weebers JE (2015). Delay in Diagnosis of Testicular Cancer; A Need for Awareness Programs. PLoS One, 10(11):e0141244.

Miri-Moghaddam E, Naderi M, Izadi S, Mashhadi M (2012). Causes of new cases of major thalassemia in sistan and balouchistan province in South-East of iran. Iran J Public Health, 41(11):67-71.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.